Safety and immunogenicity of different booster vaccination schemes for COVID-19 used in El Salvador

Clinical and Experimental Vaccine Research · Published 2024-01-01 · DOI 10.7774/cevr.2024.13.1.35

Authors being retrieved — see the publisher record. https://doi.org/10.7774/cevr.2024.13.1.35

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2024

Related articles

Temporal dynamics of IgM and IgG after COVID-19 vaccination: a pilot cohort study on breakthrough infections · Clinical and Experimental Vaccine Research · 2026 · Same journal
Evaluation of the safety and immunogenicity of the ERAGS-GFP oral rabies vaccine in dogs · Clinical and Experimental Vaccine Research · 2025 · Same journal
Identification of conserved CD8+ T cell epitopes in Nipah virus towards vaccine development using an immunoinformatics approach · Clinical and Experimental Vaccine Research · 2025 · Same journal
The BCG vaccine, advantages, and disadvantages of introducing new generation vaccines against Mycobacterium tuberculosis · Clinical and Experimental Vaccine Research · 2024 · Same journal
Optimizing vaccine allocation: a review of epidemiological models with behavioral adaptation · Clinical and Experimental Vaccine Research · 2025 · Same journal
How does geographical diversity shape vaccine efficacy? · Clinical and Experimental Vaccine Research · 2024 · Same journal
A promising Staphylococcus aureus vaccine adjuvant candidate to overcome Staphylococcal infection based on innate immunity · Clinical and Experimental Vaccine Research · 2025 · Same journal
Impact of vitamin D and zinc sufficiency on immune responses following COVID-19 vaccinations among healthcare workers · Clinical and Experimental Vaccine Research · 2025 · Same journal
Minireview: Designing next generation human metapneumovirus (HMPV) vaccine · Clinical and Experimental Vaccine Research · 2025 · Same journal
Discovery of novel vaccine candidates based on the immunogenic epitopes derived from Toxoplasma membrane proteins · Clinical and Experimental Vaccine Research · 2025 · Same journal